There were no significant differences between total Hsp90 levels in NAFLD patients compared to non-NAFLD patients (median 16.14 ng/mL (7.06-123.8) versus 25.7 ng/mL (5.52-105.90), Mann-Whitney U test, Figure 1). This evidence concerns the gene HSP90AB1 and metabolic dysfunction-associated steatotic liver disease.